전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
• ganirelix and its salts and derivatives glimépiride
• ganirélix, ses sels et dérivés glimepiride
마지막 업데이트: 2015-05-14
사용 빈도: 1
품질:
orgalutran 0,25 mg/ 0,5 ml solution injectable ganirelix
orgalutran 0.25 mg/0.5 ml solution for injection ganirelix
마지막 업데이트: 2017-04-26
사용 빈도: 5
품질:
on ignore si le ganirelix est excrété dans le lait maternel.
it is not known whether ganirelix is excreted in breast milk.
마지막 업데이트: 2017-04-26
사용 빈도: 4
품질:
chaque seringue contient 0,25 mg du principe actif ganirelix.
each syringe contains 0.25 mg of the active substance, ganirelix.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
le ganirelix est aussi le composant principal trouvé dans l’urine.
ganirelix is also the main compound found in urine.
마지막 업데이트: 2017-04-26
사용 빈도: 4
품질:
orgalutran 0,25 mg/ 0,5 ml solution injectable ganirelix voie sous-cutanée
orgalutran 0.25 mg/ 0.5 ml solution for injection ganirelix subcutaneous use
마지막 업데이트: 2011-10-23
사용 빈도: 2
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
5 petits fragments peptidiques formés par hydrolyse enzymatique du ganirelix survenant en des sites limités.
the metabolites are small peptide fragments formed by enzymatic hydrolysis of ganirelix at restricted sites.
마지막 업데이트: 2012-04-11
사용 빈도: 3
품질:
chaque seringue pré-remplie contient 0,25 mg de ganirelix dans 0,5 ml de solution aqueuse.
each pre-filled syringe contains 0.25 mg of ganirelix in 0.5 ml aqueous solution.
마지막 업데이트: 2017-04-26
사용 빈도: 4
품질:
il n'existe pas de données pertinentes concernant l'utilisation du ganirelix chez la femme enceinte.
there are no adequate data from the use of ganirelix in pregnant women.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
-si vous êtes allergique (hypersensible) au ganirelix ou à l'un des autres composants contenus
-if you are allergic (hypersensitive) to ganirelix or any of the other ingredients of orgalutran;
마지막 업데이트: 2008-03-04
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
au moins une dose posologique parentérale contenant un ou plusieurs antagonistes de gnrh en quantité équivalente à une dose sous-cutanée de 0,5 -25 mg de ganirelix
-at least one parenteral dosage unit containing one or more gnrh antagonists in an amount equivalent to a subcutaneous dose of 0.5 -25 mg ganirelix
마지막 업데이트: 2011-07-27
사용 빈도: 1
품질:
chez les animaux, une exposition au ganirelix au moment de l’implantation a abouti à une résorption de la portée (voir rubrique 5.3).
in animals, exposure to ganirelix at the time of implantation resulted in litter resorption (see section 5.3).
마지막 업데이트: 2017-04-26
사용 빈도: 4
품질:
le principe actif d’ orgalutran, le ganirelix, inhibe les effets d’ une hormone naturelle, appelée hormone de libération de gonadotrophine (gnrh).
the active substance in orgalutran, ganirelix, blocks the effects of a natural hormone, called gonadotrophin-releasing hormone (gnrh).
마지막 업데이트: 2012-04-11
사용 빈도: 3
품질: